Most Popular Stories
- Hospitals lose reimbursement for 'unnecessary' ER visits
- Healthcare jobs will grow the fastest of all industries
- Online tools, social media ease clinical recruiting, research
- Hospital exec arrested in $116M Medicare scheme
- Docs not always honest with patients
- Medicaid cuts loom despite overdue reimbursements
Featured Jobs
-
Epic Ambulatory Beacon Consultant
Meditology Services - NC -
Electronic Health Records Application Support Manager RN-New Year New Career
Avanti on behalf of Respected Health System - San Francisco, CA -
ICD-10 Revenue Cycle, Manager
Meditology Services - Atlanta, GA
Events
- IHI's Transforming the Primary Care Practice
May 1-3, 2012 — San Diego, CA - Medicare Risk Adjusted Revenue and Plan Payments
April 12 - 13, 2012 — Baltimore, MD - From IHI: The Patient Experience Seminar
March 27-28 — Boston, MA - Medical Devices Summit 2012
March 6-7 2012 — The Boston Park Plaza Hotel & Towers, Boston, MA
Paid Research Reports
- Electronic health records: getting it right first time
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Stakeholder Opinions: Ophthalmology - Leading brands under threat
- Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
- Healthcare Regulatory Update: The United Arab Emirates
- Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
A flight of pharma marketing fancy
![]()

With New York becoming yet another state to consider regulating pharmaceutical company gift-giving, it's worth considering whether such regs are likely to achieve their intended purpose.
Here's my premise: No matter how you work to restrict them, multi-billion dollar marketing concerns like the pharmas are going to find a way to peddle influence. Maybe, then, we should accept this and base pharma reforms on this premise.
Indulge in a flight of fantasy with me here.
What if, rather than competing with potentially questionable gifts, pharmas were required to jointly fund a U.S. educational pool. This pool would pay for reps to present on various drugs from multiple pharmaceutical companies.
Reps would definitely give sales pitches, and be compensated for their success, but would make the same bucks no matter which company they pitched on a given day.
Because there would be less money spent on building out competing sales forces, the reps could be paid more, which might attract clinical professionals to get involved, upping the quality of physician-rep discussion considerably.
The pool would pay for educational materials, but the materials would be conducted by a related research institute with no direct ties to the pharma industry. The institute would be funded indirectly through the pool.
Doctors could visit regional "educational centers" when they wanted to get current, and would be reimbursed for their time through the pool. Again, pharmas could put their pitches to work, but no one company would have funded the entire works.
Sure, the idea isn't practical, but in my mind, that's how things should work. This would let the pharmas spend all they want on promotions, but take some of the undue influence out of the process.
What do you think, folks. Is this a pipe dream, a possibility or something which could actually work? - Anne
Related Stories
- Big drug companies wield too much influence over doctors
- Dems tackle Medicare drug costs
- Conflicts of interest remain as docs receive $760M from drug makers
- Harvard docs punished for conflict of interest violations; ties to pharma
- Feds to create new center to speed drug development
- Colorado teaching hospitals overhaul conflict of interest rules
- Med school docs still break conflict-of-interest rules
- Study: Attitudes over doctor-industry ties not as evolved as we think
- SPOTLIGHT: Relationships between docs, drug companies also a problem in India
- Price hikes could raise $10 billion in additional income for pharmas
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map
| Editors | List in Marketplace | Supplier in MarketplaceTHE FIERCEMARKETS NETWORKFierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2011 FierceMarkets. All rights reserved. |
![]() |
